These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 1095958

  • 1. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
    [No Abstract] [Full Text] [Related]

  • 2. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
    [No Abstract] [Full Text] [Related]

  • 3. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
    Valiensi M, Riboli E, Lombardi M.
    Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
    [No Abstract] [Full Text] [Related]

  • 4. [Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
    Meciani L, Boeri S, Ricci G.
    Minerva Cardioangiol; 1974 Feb; 22(7-8):512-42. PubMed ID: 4606052
    [No Abstract] [Full Text] [Related]

  • 5. [The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
    Parodi FA, Caputo G.
    Clin Ter; 1976 Dec 31; 79(6):571-81. PubMed ID: 1009761
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
    Bagliani A, Borri P, Parravicini R.
    Minerva Cardioangiol; 1975 Nov 31; 23(11):701-10. PubMed ID: 1223674
    [No Abstract] [Full Text] [Related]

  • 7. [Effectiveness of pyridinolcarbamate in the overall treatment of infiltrative and cavernous-fibrous pulmonary tuberculosis].
    Makinskiĭ AI, Safarov RN, Fondaminskaia LD, Semenova AS, Fedotova NN.
    Probl Tuberk; 1979 Jan 31; (1):26-30. PubMed ID: 368764
    [No Abstract] [Full Text] [Related]

  • 8. The use of prodectin in the treatment of cerebral arteriosclerosis and its complications.
    Abrányi I, Máté.
    Ther Hung; 1976 Jan 31; 24(1):20-3. PubMed ID: 790631
    [No Abstract] [Full Text] [Related]

  • 9. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV.
    Vrach Delo; 1976 Jan 31; (1):27-30. PubMed ID: 1246850
    [No Abstract] [Full Text] [Related]

  • 10. [Current trends in the therapy of arteriosclerotic disease].
    Toscano S.
    G Clin Med; 1974 Jan 31; 55(1):27-39. PubMed ID: 4369524
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
    Roztocil K, Oliva I, Linhart J, Prerovský I, Modr Z.
    Cas Lek Cesk; 1976 Aug 27; 115(33-34):1051-5. PubMed ID: 975177
    [No Abstract] [Full Text] [Related]

  • 14. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
    Tirkina TN, Aleksandrova LM, Kliachko VR, Mazovetskiĭ AG.
    Ter Arkh; 1974 Aug 27; 46(1):107-10. PubMed ID: 4453966
    [No Abstract] [Full Text] [Related]

  • 15. [Influence of pyridinolcarbamate on platelet aggregation in diabetic subjects with ischemic cardiopathy].
    Citarrella P, Abbadessa V, Pecorella M, Cajozzo A.
    Boll Soc Ital Cardiol; 1977 Aug 27; 22(7):1036-41. PubMed ID: 618239
    [No Abstract] [Full Text] [Related]

  • 16. [Evaluation of the effectiveness of anginine treatment of diabetic microangiopathies].
    Spesivtseva VG, Frenkel' VKh, Mamaeva GG, Sokolovskiĭ GA, Kukes VG.
    Sov Med; 1975 Jul 27; (7):42-5. PubMed ID: 1216049
    [No Abstract] [Full Text] [Related]

  • 17. [Value of pyridinol carbamate in ocular vascular pathology (Angioxine)].
    Boudet, Millet, Arnaud.
    Bull Soc Ophtalmol Fr; 1974 Jul 27; 74(9-10):977-80. PubMed ID: 4470033
    [No Abstract] [Full Text] [Related]

  • 18. Attempts to delay progression in occlusive atherosclerosis.
    Terry EN, Rouen LR, Clasuss RH, Katz MC, Redisch W.
    Ann N Y Acad Sci; 1976 Jul 27; 275():379-85. PubMed ID: 1070279
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of chronic ischemic cardiopathy with a combination of pyridinolcarbamate and clofibrate].
    Guerrera G, Melina D.
    Clin Ter; 1980 Mar 15; 92(5):533-47. PubMed ID: 7449327
    [No Abstract] [Full Text] [Related]

  • 20. A multiclinic double-blind trial of pyridinolcarbamate and inositol niacinate in ischemic ulcer due to chronic arterial occlusion.
    Mishima Y, Kamiya K, Sakaguchi S, Kusaba A, Sakuma A.
    Angiology; 1977 Feb 15; 28(2):84-94. PubMed ID: 326097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.